Guidance predicting therapy response in IgAN is currently lacking although controlled studies have yielded reductions in proteinuria. To serve this urgent need, the project aims at developing an urine-proteomic biomarker-based algorithm that predicts immunosuppressive drug response in IgAN, personalizing intervention and significantly improving patient management.